Combination therapy with SYY plus IFN-α, by regulating the MMP2/TIMP2 ratio and VEGF expression, could be an effective therapeutic strategy to reverse the tumor-enhancing effect derived from hepatectomy. The gene discussed is VEGFA; the disease is neoplasm.